New registry aims to unlock secrets of neuroendocrine tumors
NCT ID NCT02270567
First seen Nov 15, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study is creating a registry of 400 people with neuroendocrine tumors (NETs). Researchers will collect blood samples and health data over time to see if certain biomarkers can help detect tumors earlier, predict treatment response, and monitor for recurrence. The goal is to improve how NETs are diagnosed and managed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wren Laboratories
Branford, Connecticut, 06405, United States
Conditions
Explore the condition pages connected to this study.